European headquarters' relocation
Velocity11 has announced the relocation of its European headquarters to larger purpose built offices in the UK. This move reflects the company's successful product introductions and an increase in installed systems during the last 18 months.
Velocity11 has announced the relocation of its European headquarters to larger purpose built offices in the UK. This move reflects the company's successful product introductions and an increase in installed systems during the last 18 months.
The company's European sales represent a sizeable and growing percentage of its global turnover and the strongest customer interest has been experienced in the automation solutions it provides for screening and plate replication. The European sales manager, Gerry Alden, commented, "The new facility marks a further investment in our growing base of customers..." adding, "...we are also planning to recruit further experienced staff to enable us to maintain the high level of informed support and service we provide to customers across Europe."
The new location of the European headquarters is in Melbourn, Hertfordshire, UK.
For more information please visit the company's website at www.velocity11.com
Facility for proteomic profiling
Cenix Biosystems, Applied Biosystems and the Biotechnology Centre (Biotec) of the Technische Universität Dresden have announced a collaboration to establish a joint facility. This facility will be used for proteomic profiling of RNAi and drug effects in human cells.
The project is expected to take two years and will enable scientists from three organizations to develop and deliver novel research tools and methodologies that enable detailed and probative analyses of the cellular functions of therapeutically-relevant genes. A German federal grant of €1.2 million has been issued to support the efforts of the project through the BioChance Plus grant programme.
The three companies bring complementary core competencies to the project. Cenix BioScience will contribute a gene silencing technology for the discovery and functional characterization of novel therapeutic target genes and drug candidates. Integrated genetic and proteomic systems technology as well as RNAi reagents will be provided by Applied Biosystems. The Biotec centre of the Technische Universität Dresden combines dynamic academic training programmes with interdisciplinary research in biotechnology.
For more information visit the companies' websites at www.cenix-bioscience.com, http://www.appliedbiosystems.com/ or http://www.biotec.tu-dresden.de/
Erratum
The article titled "2D Polymer LC as a High-Speed, High-Throughput Application" by Martina Adler and Peter Kilz from PSS Polymer Standards Service GmbH, Mainz, Germany (LCGC Eur., 19(10) 552–556 (2006) has two lines of text missing from the first paragraph.
The paragraph should read "The combination of independent separation techniques improves the chromatographic resolution because of increased peak capacity, which is not the sum but the product of the peak capacities of each technique". We apologize for any inconvenience caused.
The full article can be viewed on LCGC Europe's website at www.lcgceurope.com
Genome Canada sponsorship
SGE Group and its division ETP Electron Multipliers have announced their sponsorship of the Genome Canada project at the University of Toronto.
SGE is sponsoring the development of a new generation of instrumentation in the form of a mass spectrometer-based flow cytometer, including associated methods and applications. Its division has provided the group with two FAST TOF detectors for use in the project.
For more information please visit SGE's website at www.sge.com
Baby oyster feed
Researchers in the Physiology and Biotechnology of Algae Laboratory at Ifremer, the French Research Institute for the Exploitation of the Sea, are using pumps from KNF Flodos in their photobioreactors. The microprocessor-controlled STEPDOS pumps will cultivate microalgae as food for oyster larvae.
Dr Gaël Bougaran, head of the microalgae cultivation projects, explained, "We rely on the STEPDOS pumps to maintain a very accurate and consistent flow of nutrients to the photobioreactors, continuously for up to three months. If the flow-rate changes, all the results will change, so it is critical to have the best possible accuracy."
For more information visit the company's website at www.knf-flodos.ch
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
